Communiqués Bioretec Oy

Actions

BRETEC

FI4000480454

Marché Fermé - Nasdaq Helsinki Autres places de cotation 17:29:50 04/06/2024			Varia. 5j.	Varia. 1 janv.
2,72 ^EUR	+4,21 %		+2,26 %	+13,33 %

21/05	La société de dispositifs médicaux Bioretec nomme un nouveau PDG	MT
20/05	Bioretec Ltd. annonce le transfert de Timo Lehtonen du poste de chef de la direction à celui de directeur de la technologie	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings - Ilmarinen Mutual Pension Insurance Company	21/05	AQ
Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (Stephen Industries Inc Oy)	20/05	AQ
Inside information: Alan Donze has been appointed as Bioretec's new CEO	20/05	AQ
Bioretec Ltd's business review January-March 2024: Controlled launch in the U.S. progresses	16/05	AQ
Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors	26/04	AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd	08/04	AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd	05/04	AQ
Inside information: Bioretec's RemeOs™ biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office	21/03	AQ
Bioretec Ltd's Annual Report and Financial Statements 2023 published	15/03	AQ
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage	14/03	AQ
Bioretec Ltd's financial statements bulletin 2023: Another successful year in the growth trajectory	16/02	AQ
Bioretec and Stephen Industries donate medical devices to Ukraine	08/02	AQ
New shares in Bioretec Ltd subscribed with option rights have been registered into the Trade Register	18/01	AQ
Bioretec Ltd - Managers' transactions	05/01	AQ
Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy	11/12	AQ
Inside information: Bioretec's Board of Directors to initiate a new CEO recruitment process	16/11	AQ
Bioretec Ltd - Managers' transactions	30/10/23	AQ
Bioretec Ltd's Board of Directors has decided on a new option program 2023-1	20/10/23	AQ
Inside information: Bioretec estimates that the approval of the European market authorization for the biodegradable RemeOs™ trauma screw will move to the first quarter of 2024	18/10/23	AQ
New shares in Bioretec Ltd subscribed with option rights have been registered into the Trade Register	10/10/23	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Bioretec Oy

Actions

BRETEC

FI4000480454

Communiqués

Filtres